Formulation comprising GLP-1

The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the pres...

Full description

Saved in:
Bibliographic Details
Main Authors MCGILL JOHN MCNEILL, JONES BRYAN EDWARD, KHAN MOHAMMED AMIN
Format Patent
LanguageEnglish
Published 23.07.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
AbstractList The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
Author KHAN MOHAMMED AMIN
JONES BRYAN EDWARD
MCGILL JOHN MCNEILL
Author_xml – fullname: MCGILL JOHN MCNEILL
– fullname: JONES BRYAN EDWARD
– fullname: KHAN MOHAMMED AMIN
BookMark eNrjYmDJy89L5WSQccsvyi3NSSzJzM9TSM7PLSjKLM7MS1dw9wnQNeRhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGhwRYmlkbGxgZORsZEKAEAEhUk2Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US8492330B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US8492330B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US8492330B23
Notes Application Number: US201113004964
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130723&DB=EPODOC&CC=US&NR=8492330B2
ParticipantIDs epo_espacenet_US8492330B2
PublicationCentury 2000
PublicationDate 20130723
PublicationDateYYYYMMDD 2013-07-23
PublicationDate_xml – month: 07
  year: 2013
  text: 20130723
  day: 23
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies EMISPHERE TECHNOLOGIES, INC
KHAN MOHAMMED AMIN
JONES BRYAN EDWARD
MCGILL JOHN MCNEILL
RelatedCompanies_xml – name: KHAN MOHAMMED AMIN
– name: JONES BRYAN EDWARD
– name: MCGILL JOHN MCNEILL
– name: EMISPHERE TECHNOLOGIES, INC
Score 2.903344
Snippet The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Formulation comprising GLP-1
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130723&DB=EPODOC&locale=&CC=US&NR=8492330B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-J0Sg_SWzA2bVMPRWjaOsRtxa2y20hDCrvM4Sr--76EbnrRW0jg5QPeZ957P4Dbh5pqpStO6spEq2o_IJJpTgKDbRFQH3WgqXcejcNh6T_Pg3kHlttaGNsn9Ms2R0SOUsjvjZXX658gVmpzKzd31RKn3h_zWZy6rXeMApl7zE2TOCsm6US4QsTl1B2_xpFpRMZogtJ6D61obrK_srfEFKWsf2uU_Bj2CyS2ak6go1c9OBRb4LUeHIza_24ctqy3OYVBjtZli7XlmERw5E5UO87TS0Huz8DJs5kYEtxmsbvSopzuDsTOoYuevr4ARxt_0ZhsUqPXRJVUIZMq4jVlMvQi2of-n2Qu_1m7giPPojhw4rEBdJuPT32NurSpbuwrfAMeUXcm
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1ag6S2-KazctDEPIyapIGm0hvJQkb6KUtNuLfd3ZJqxe9Lbsw-4B57sx8ALcPDeU1ryzSVCJa1egGKRm3iCGwLQyqow4U9c5JakaF_jIzZj1YbGthZJ_QL9kcETmqRn5vpbxe_wSxfJlbubmrFji1egxzx1c77xgFsqUx1XedIJv4E0_1PKeYqumbY4tGZIy6KK330MK2RZv94N0VRSnr3xolPIL9DIkt22Po8eUQBt4WeG0IB0n3343DjvU2JzAO0brssLYUkQiO3IlqR3mKM3J_CkoY5F5EcJv57krzYro7EDuDPnr6_BwULvxFYbKVHL0mWpe1ycrathrKSlOz6QhGf5K5-GftBgZRnsTz-Dl9vYRDTSI6WERjY-i3H5_8CvVqW13LF_kG28Z6Fg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Formulation+comprising+GLP-1&rft.inventor=MCGILL+JOHN+MCNEILL&rft.inventor=JONES+BRYAN+EDWARD&rft.inventor=KHAN+MOHAMMED+AMIN&rft.date=2013-07-23&rft.externalDBID=B2&rft.externalDocID=US8492330B2